Sunshine Biopharma Stock Surges Over 152%, Reverse Split Proposal Sparks Investor Interest Amid Nasdaq Battle
In the tumultuous world of stock trading, Sunshine Biopharma finds itself at a crossroads yet again, grappling with the stringent requirements set by Nasdaq as
